Cargando…

Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders

Melatonin is registered to treat circadian rhythm sleep–wake disorders and insomnia in patients aged 55 years and over. The essential role of the circadian sleep rhythm in the deterioration of sleep quality during COVID-19 confinement and the lack of an adverse effect of melatonin on respiratory dri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wichniak, Adam, Kania, Aleksander, Siemiński, Mariusz, Cubała, Wiesław Jerzy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395320/ https://www.ncbi.nlm.nih.gov/pubmed/34445329 http://dx.doi.org/10.3390/ijms22168623

Ejemplares similares

Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
por: Kwaśny, Aleksander, et al.
Publicado: (2023)

Cortisol awakening response in drug-naïve panic disorder
por: Jakuszkowiak-Wojten, Katarzyna, et al.
Publicado: (2016)

Residual insomnia in major depressive disorder: a systematic review
por: Kwaśny, Aleksander, et al.
Publicado: (2023)

Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports
por: Wilkowska, Alina, et al.
Publicado: (2019)

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2023)

Safety and Tolerability of Ketamine Use in Treatment-Resistant Bipolar Depression Patients with Regard to Central Nervous System Symptomatology: Literature Review and Analysis
por: Włodarczyk, Adam, et al.
Publicado: (2020)

COVID-19: Melatonin as a potential adjuvant treatment
por: Zhang, Rui, et al.
Publicado: (2020)

Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
por: Włodarczyk, Adam, et al.
Publicado: (2023)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Potential Neuroprotective Role of Melatonin in Sepsis-Associated Encephalopathy Due to Its Scavenging and Anti-Oxidative Properties
por: Sieminski, Mariusz, et al.
Publicado: (2023)

Multiple Comorbidity Profile of Psychiatric Disorders in Epilepsy
por: Grzegorzewska, Agata M., et al.
Publicado: (2021)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2022)

Correspondence COVID-19: Melatonin as a potential adjuvant treatment
por: Salles, Cristina
Publicado: (2020)

Comment on Melatonin as a potential adjuvant treatment for COVID-19
por: Herrera, Emilio A., et al.
Publicado: (2020)

Long-Term Treatment with Trazodone Once-A-Day (TzOAD) in Patients with MDD: An Observational, Prospective Study
por: Shrashimirova, Milena, et al.
Publicado: (2023)

Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals
por: Mechlińska, Agnieszka, et al.
Publicado: (2023)

Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2021)

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2020)

Ketogenic Diet: A Dietary Modification as an Anxiolytic Approach?
por: Włodarczyk, Adam, et al.
Publicado: (2020)

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study
por: Szarmach, Joanna, et al.
Publicado: (2017)

Comment on ‘The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the quality of life of people with epilepsy’
por: Grzegorzewska, Agata M., et al.
Publicado: (2023)

Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor
por: Cubała, Wiesław Jerzy, et al.
Publicado: (2010)

Melatonin, Zinc, and Vitamin C: Potential Adjuvant Treatment for COVID-19 Patients
por: Borges, Leandro, et al.
Publicado: (2022)

Orexins, Sleep, and Blood Pressure
por: Sieminski, Mariusz, et al.
Publicado: (2018)

Dietary Patterns of Treatment–Resistant Depression Patients
por: Mechlińska, Agnieszka, et al.
Publicado: (2022)

Effects of Antidepressants on Sleep
por: Wichniak, Adam, et al.
Publicado: (2017)

Periodic limb movements in sleep are followed by increases in EEG activity, blood pressure, and heart rate during sleep
por: Sieminski, Mariusz, et al.
Publicado: (2017)

Series of periodic limb movements in sleep and heart rate variability
por: Małkiewicz, M. A., et al.
Publicado: (2023)

Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
por: Ferracioli-Oda, Eduardo, et al.
Publicado: (2013)

Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments
por: González, Alicia, et al.
Publicado: (2021)

Dysphoria and Irritability—Diagnostic Pitfalls in the Assessment of Interictal Dysphoric Disorder in Epilepsy
por: Grzegorzewska, Agata M., et al.
Publicado: (2021)

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
por: Wilkowska, Alina, et al.
Publicado: (2021)

Changes in T-Cell Subpopulations and Cytokine Levels in Patients with Treatment-Resistant Depression—A Preliminary Study
por: Szałach, Łukasz Piotr, et al.
Publicado: (2022)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
por: Górska, Natalia, et al.
Publicado: (2021)

Pineal hormone melatonin as an adjuvant treatment for COVID-19 (Review)
por: Vlachou, Marilena, et al.
Publicado: (2021)

Melatonin and melatonergic drugs in sleep disorders
por: Kim, Hyung Ki, et al.
Publicado: (2022)

Evaluating the Potential Effect of Melatonin on the post-Cardiac Surgery Sleep Disorder
por: Dianatkhah, Mehrnoush, et al.
Publicado: (2015)

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2021)

Ketamine in Bipolar Disorder: A Review
por: Wilkowska, Alina, et al.
Publicado: (2020)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f8gkoi9ab3f7imce65qngloaul